Laurent Sabbagh

Company: DOMAIN Therapeutics

Job title: Scientific Director

Seminars:

Early-Stage Development of BRET-Based Assays to Characterize the Activation of the Human Adhesion GPCR ADGRE5 9:00 am

Applying mechano-stimulation to study human ADGRE5 activation revealed by BRET-based biosensors Demonstrating the mechanistic aspects of ADGRE5 receptor activation and impact on actin remodeling, exposing a possible mechanism by which hADGRE5 may promote tumor metastasis Showcasing the future for the application of different technologies to study adhesion GPCR biology and develop screening assays to identify…Read more

day: Day One